A pharmaceutical company will pay $280 million to settle fraud allegations made in Los Angeles related to the marketing of cancer treatment drugs for uses not approved by the U.S. Food and Drug Administration, the Department of Justice has announced. The whistleblower lawsuit filed in Los Angeles federal court alleged New Jersey-based Celgene Corp. used […]
